Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.38 Down 0.02(1.43%) 4:00PM EDT
- Nasdaq Real Time Price
Prev Close:1.40
Open:1.40
Bid:1.38 x 3500
Ask:1.39 x 74000
1y Target Est:2.81
Beta:0.92
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:1.35 - 1.40
52wk Range:1.11 - 3.31
Volume:319,227
Avg Vol (3m):997,827
Market Cap:205.94M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.43%205.94M
LLYUp 0.83%68.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):110.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback